Davita Stock Price, News & Analysis (NYSE:DVA)

$79.13 -0.90 (-1.12 %)
(As of 01/16/2018 04:00 PM ET)
Previous Close$80.03
Today's Range$79.02 - $80.03
52-Week Range$52.51 - $80.71
Volume1.44 million shs
Average Volume1.71 million shs
Market Capitalization$14.54 billion
P/E Ratio30.32
Dividend YieldN/A
Beta0.96

About Davita (NYSE:DVA)

Davita logoDaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorHealthcare
SymbolNYSE:DVA
CUSIP23918K10
Phone+1-310-5362668

Debt

Debt-to-Equity Ratio1.79%
Current Ratio1.40%
Quick Ratio1.35%

Price-To-Earnings

Trailing P/E Ratio30.3180076628353
Forward P/E Ratio23.14
P/E GrowthN/A

Sales & Book Value

Annual Sales$14.75 billion
Price / Sales0.98
Cash Flow$7.52 per share
Price / Cash10.52
Book Value$24.16 per share
Price / Book3.28

Profitability

Trailing EPS$2.61
Net Income$879.87 million
Net Margins3.40%
Return on Equity13.31%
Return on Assets3.55%

Miscellaneous

Employees70,300
Outstanding Shares183,300,000

Davita (NYSE:DVA) Frequently Asked Questions

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How will Davita's stock buyback program work?

Davita announced that its board has authorized a stock buyback plan on Wednesday, October 11th 2017, which permits the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company's board believes its shares are undervalued.

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) issued its quarterly earnings data on Tuesday, November, 7th. The company reported $0.81 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.94 by $0.13. The company earned $3.92 billion during the quarter, compared to the consensus estimate of $3.91 billion. Davita had a net margin of 3.40% and a return on equity of 13.31%. Davita's revenue was up 5.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.95 EPS. View Davita's Earnings History.

When will Davita make its next earnings announcement?

Davita is scheduled to release their next quarterly earnings announcement on Thursday, February, 15th 2018. View Earnings Estimates for Davita.

Where is Davita's stock going? Where will Davita's stock price be in 2018?

11 equities research analysts have issued twelve-month price targets for Davita's stock. Their forecasts range from $60.00 to $95.00. On average, they anticipate Davita's stock price to reach $78.22 in the next twelve months. View Analyst Ratings for Davita.

Who are some of Davita's key competitors?

Who are Davita's key executives?

Davita's management team includes the folowing people:

  • Kent J. Thiry, Chairman of the Board (Age 61)
  • James K. Hilger, Interim Chief Financial Officer, Chief Accounting Officer (Age 55)
  • Joel Ackerman, Chief Financial Officer (Age 51)
  • Robert Lang, President, International Business
  • Javier J. Rodriguez, Chief Executive Officer - Kidney Care (Age 46)
  • Jeanine M. Jiganti, Chief Compliance Officer (Age 57)
  • LeAnne M. Zumwalt, Group Vice President - purchasing and government affairs (Age 58)
  • Kathleen Alyce Waters, Chief Legal Officer (Age 49)
  • Peter T. Grauer, Lead Director, Independent Director (Age 71)
  • Pamela M. Arway, Independent Director (Age 63)

Who owns Davita stock?

Davita's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Hikari Power Ltd (0.18%), DnB Asset Management AS (0.14%), Founders Capital Management LLC (0.05%), Exxonmobil Investment Management Inc. TX (0.01%) and Country Club Trust Company n.a. (0.00%). Company insiders that own Davita stock include Charles Berg, Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway, Roger Valine and William L Roper. View Institutional Ownership Trends for Davita.

Who sold Davita stock? Who is selling Davita stock?

Davita's stock was sold by a variety of institutional investors in the last quarter, including DnB Asset Management AS, Exxonmobil Investment Management Inc. TX and Founders Capital Management LLC. Company insiders that have sold Davita company stock in the last year include Charles Berg, James K Hilger, Javier Rodriguez, Kent J Thiry, Leanne M Zumwalt and William L Roper. View Insider Buying and Selling for Davita.

Who bought Davita stock? Who is buying Davita stock?

Davita's stock was purchased by a variety of institutional investors in the last quarter, including Hikari Power Ltd and Country Club Trust Company n.a.. View Insider Buying and Selling for Davita.

How do I buy Davita stock?

Shares of Davita can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Davita's stock price today?

One share of Davita stock can currently be purchased for approximately $79.13.

How big of a company is Davita?

Davita has a market capitalization of $14.54 billion and generates $14.75 billion in revenue each year. The company earns $879.87 million in net income (profit) each year or $2.61 on an earnings per share basis. Davita employs 70,300 workers across the globe.

How can I contact Davita?

Davita's mailing address is 2000 16th St, DENVER, CO 80202-5158, United States. The company can be reached via phone at +1-310-5362668 or via email at [email protected]


MarketBeat Community Rating for Davita (DVA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  310 (Vote Outperform)
Underperform Votes:  326 (Vote Underperform)
Total Votes:  636
MarketBeat's community ratings are surveys of what our community members think about Davita and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Davita (NYSE:DVA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.642.551.892.10
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
2 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $78.22$73.33$65.00$68.67
Price Target Upside: 2.26% downside5.50% upside18.76% upside5.82% upside

Davita (NYSE:DVA) Consensus Price Target History

Price Target History for Davita (NYSE:DVA)

Davita (NYSE:DVA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/12/2018Robert W. BairdReiterated RatingBuy$82.00 -> $95.00LowView Rating Details
1/11/2018Bank of AmericaReiterated RatingBuy$85.00 -> $92.00HighView Rating Details
12/21/2017SunTrust BanksSet Price TargetHold$75.00LowView Rating Details
12/11/2017CitigroupUpgradeNeutral -> Buy$67.71 -> $82.00MediumView Rating Details
12/7/2017JPMorgan Chase & Co.Boost Price TargetOutperform -> Strong-Buy$4.90 -> $84.00LowView Rating Details
12/7/2017Raymond James FinancialUpgradeOutperform -> Strong-Buy$65.00 -> $84.00HighView Rating Details
12/6/2017KeyCorpReiterated RatingHoldLowView Rating Details
11/8/2017Royal Bank of CanadaLower Price TargetSector Perform$64.00 -> $60.00N/AView Rating Details
10/23/2017Wolfe ResearchUpgradeMarket Perform -> OutperformN/AView Rating Details
8/3/2017Jefferies GroupReiterated RatingHold$70.00MediumView Rating Details
5/25/2017Goldman Sachs GroupReiterated RatingSell$62.00HighView Rating Details
11/1/2016Wells Fargo & CoReiterated RatingOutperformN/AView Rating Details
4/6/2016Susquehanna BancsharesBoost Price TargetNeutral$70.00 -> $78.00N/AView Rating Details
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00N/AView Rating Details
2/12/2016William BlairReiterated RatingBuyN/AView Rating Details
2/12/2016Piper Jaffray CompaniesReiterated RatingOverweight$90.00 -> $85.00N/AView Rating Details
(Data available from 1/16/2016 forward)

Earnings

Davita (NYSE:DVA) Earnings History and Estimates Chart

Earnings by Quarter for Davita (NYSE:DVA)

Davita (NYSE DVA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/14/2018$0.92N/AView Earnings Details
11/7/2017Q3 2017$0.94$0.81$3.91 billion$3.92 billionViewN/AView Earnings Details
8/1/2017Q2 2017$0.90$0.92$3.82 billion$3.88 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.82$0.79$3.69 billion$3.70 billionViewListenView Earnings Details
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.72 billionViewListenView Earnings Details
11/2/2016Q316$0.94$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.53 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.53 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.43 billionViewListenView Earnings Details
5/4/2015Q115$0.86$0.86$3.25 billion$3.29 billionViewListenView Earnings Details
2/12/2015Q414$0.89$0.96$3.26 billion$3.33 billionViewListenView Earnings Details
11/6/2014Q314$0.91$0.90$3.19 billion$3.25 billionViewListenView Earnings Details
7/31/2014Q214$0.88$0.95$3.10 billion$3.17 billionViewListenView Earnings Details
5/1/2014Q1$0.87$0.85$3.02 billion$3.04 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$3.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.87 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.83 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
5/1/2012Q1 2012$0.73$0.73ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
11/4/2010Q3 2010$0.57$0.57ViewN/AView Earnings Details
8/2/2010Q2 2010$0.54$0.53ViewN/AView Earnings Details
4/27/2010Q1 2010$0.52$0.52ViewN/AView Earnings Details
2/10/2010Q4 2009$0.53$0.53ViewN/AView Earnings Details
11/3/2009Q3 2009$0.50$0.53ViewN/AView Earnings Details
8/4/2009Q2 2009$0.48$0.51ViewN/AView Earnings Details
4/27/2009Q1 2009$0.45$0.46ViewN/AView Earnings Details
2/10/2009Q4 2008$0.45$0.47ViewN/AView Earnings Details
11/3/2008Q3 2008$0.44$0.44ViewN/AView Earnings Details
8/4/2008Q2 2008$0.42$0.45ViewN/AView Earnings Details
4/29/2008Q1 2008$0.39$0.40ViewN/AView Earnings Details
2/13/2008Q4 2007$0.40$0.40ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Davita (NYSE:DVA) Earnings Estimates

2018 EPS Consensus Estimate: $3.59
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.77$0.80$0.79
Q2 20182$0.94$0.94$0.94
Q3 20182$0.95$0.95$0.95
Q4 20182$0.90$0.92$0.91
Q1 20191$0.85$0.85$0.85
Q2 20191$1.05$1.05$1.05
Q3 20191$1.04$1.04$1.04
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Davita (NYSE:DVA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Davita (NYSE DVA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 87.97%
Insider Trades by Quarter for Davita (NYSE:DVA)
Institutional Ownership by Quarter for Davita (NYSE:DVA)

Davita (NYSE DVA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/11/2017Charles BergInsiderSell7,048$69.24$488,003.525,359View SEC Filing  
12/8/2017Kent J ThiryChairmanSell81,800$68.04$5,565,672.00View SEC Filing  
12/8/2017Leanne M ZumwaltVPSell949$68.19$64,712.3112,423View SEC Filing  
12/7/2017James K HilgerInsiderSell5,608$69.46$389,531.6847,649View SEC Filing  
12/7/2017Javier RodriguezCEOSell22,532$67.48$1,520,459.36210,317View SEC Filing  
5/15/2017Javier RodriguezCEOSell1,294$66.21$85,675.7499,111View SEC Filing  
5/9/2017Charles BergDirectorSell8,414$65.80$553,641.2034,719View SEC Filing  
5/4/2017William L RoperDirectorSell12,994$65.89$856,174.6645,277View SEC Filing  
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.5852,279View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.415,716View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.007,590View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.8436,394View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.6429,147View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.2039,184View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.0018,766View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.048,585View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.9721,130View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.0464,264View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.4612,279View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.8018,324View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.0092,716View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.8436,665View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12317,397View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.6092,716View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.0036,070View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10120,816View SEC Filing  
1/13/2016Christopher James SchnarrInsiderBuy5,000$0.68$3,400.00
1/11/2016Christopher James SchnarrInsiderBuy10,000$0.60$6,000.00
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.608,447View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.767,438View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.0040,874View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00247,950View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.1813,277View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.0064,264View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.2859,624View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.6859,624View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.052,633View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.966,036View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.262,191,806View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.0081,766View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.034,994View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.016,036View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.072,508View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.161,095,903View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Davita (NYSE DVA) News Headlines

Source:
DateHeadline
[$$] UnitedHealth Profit Rises as Both Healthcare, Optum Businesses Grow[$$] UnitedHealth Profit Rises as Both Healthcare, Optum Businesses Grow
finance.yahoo.com - January 16 at 9:44 AM
DaVita (DVA) Partners with Epic to Launch EHR for PatientsDaVita (DVA) Partners with Epic to Launch EHR for Patients
finance.yahoo.com - January 15 at 5:09 PM
Investors Purchase Large Volume of Put Options on Davita (DVA)Investors Purchase Large Volume of Put Options on Davita (DVA)
www.americanbankingnews.com - January 15 at 3:40 AM
Robert W. Baird Reiterates "Buy" Rating for Davita (DVA)Robert W. Baird Reiterates "Buy" Rating for Davita (DVA)
www.americanbankingnews.com - January 14 at 3:34 PM
DaVita Physician Solutions Makes Its First Big Investment in New Technology from EpicDaVita Physician Solutions Makes Its First Big Investment in New Technology from Epic
finance.yahoo.com - January 11 at 5:15 PM
Davita (DVA) Stock Rating Reaffirmed by Bank of AmericaDavita (DVA) Stock Rating Reaffirmed by Bank of America
www.americanbankingnews.com - January 11 at 9:40 AM
DaVita Inc. to Present at the 36th Annual J.P. Morgan Healthcare ConferenceDaVita Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 10 at 9:46 AM
The Everett Clinic Offers Personalized Care to Bothell CommunityThe Everett Clinic Offers Personalized Care to Bothell Community
finance.yahoo.com - January 8 at 5:15 PM
TheStreet Upgrades Davita (DVA) to B-TheStreet Upgrades Davita (DVA) to B-
www.americanbankingnews.com - January 6 at 10:12 AM
DVA Crosses Above Average Analyst Target - NasdaqDVA Crosses Above Average Analyst Target - Nasdaq
www.nasdaq.com - January 5 at 4:55 PM
Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital. and Many MoreTop Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital. and Many More
www.msn.com - January 4 at 9:40 AM
TeamHealth (TMH) & Davita (DVA) Critical SurveyTeamHealth (TMH) & Davita (DVA) Critical Survey
www.americanbankingnews.com - January 3 at 8:12 AM
 Analysts Expect Davita Inc (DVA) Will Post Quarterly Sales of $3.89 Billion Analysts Expect Davita Inc (DVA) Will Post Quarterly Sales of $3.89 Billion
www.americanbankingnews.com - January 3 at 5:02 AM
Davita (DVA) Stock Rating Upgraded by Zacks Investment ResearchDavita (DVA) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - January 3 at 12:54 AM
Bloomberg Colorado stock index dips in 2017Bloomberg Colorado stock index dips in 2017
www.bizjournals.com - January 2 at 11:26 PM
Davita (DVA) vs. Chemed (CHE) Critical AnalysisDavita (DVA) vs. Chemed (CHE) Critical Analysis
www.americanbankingnews.com - January 2 at 7:30 AM
Davita Inc (DVA) Receives Average Rating of "Hold" from AnalystsDavita Inc (DVA) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - January 2 at 1:32 AM
 Analysts Expect Davita Inc (DVA) Will Post Earnings of $0.91 Per Share Analysts Expect Davita Inc (DVA) Will Post Earnings of $0.91 Per Share
www.americanbankingnews.com - January 1 at 5:08 PM
ETFs with exposure to DaVita, Inc. : January 1, 2018ETFs with exposure to DaVita, Inc. : January 1, 2018
finance.yahoo.com - January 1 at 5:03 PM
SunTrust Banks Reiterates "$75.00" Price Target for Davita (DVA)SunTrust Banks Reiterates "$75.00" Price Target for Davita (DVA)
www.americanbankingnews.com - December 22 at 7:16 AM
Mans Life Changed by Online Kidney Diet ResourcesMan's Life Changed by Online Kidney Diet Resources
finance.yahoo.com - December 21 at 5:10 PM
Analyzing Acadia Healthcare (ACHC) and Davita (DVA)Analyzing Acadia Healthcare (ACHC) and Davita (DVA)
www.americanbankingnews.com - December 19 at 9:34 PM
DaVita Kidney Care Celebrates and Shares Tips for Care Partners During the ...DaVita Kidney Care Celebrates and Shares Tips for Care Partners During the ...
www.prnewswire.com - December 19 at 5:09 PM
HealthCare Partners Honored for Performance in Clinical QualityHealthCare Partners Honored for Performance in Clinical Quality
finance.yahoo.com - December 19 at 5:09 PM
ETFs with exposure to DaVita, Inc. : December 19, 2017ETFs with exposure to DaVita, Inc. : December 19, 2017
finance.yahoo.com - December 19 at 5:09 PM
DaVita, Inc. :DVA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017DaVita, Inc. :DVA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017
finance.yahoo.com - December 18 at 5:08 PM
Update in Lawsuit for Investors in Davita Inc. (NYSE: DVA) shares announced by Shareholders FoundationUpdate in Lawsuit for Investors in Davita Inc. (NYSE: DVA) shares announced by Shareholders Foundation
finance.yahoo.com - December 18 at 10:02 AM
 Analysts Anticipate Davita Inc (DVA) Will Post Quarterly Sales of $3.89 Billion Analysts Anticipate Davita Inc (DVA) Will Post Quarterly Sales of $3.89 Billion
www.americanbankingnews.com - December 17 at 2:22 AM
 Brokerages Expect Davita Inc (DVA) to Post $0.91 EPS Brokerages Expect Davita Inc (DVA) to Post $0.91 EPS
www.americanbankingnews.com - December 15 at 11:14 PM
DaVita settles False Claims Act allegations for $64 millionDaVita settles False Claims Act allegations for $64 million
finance.yahoo.com - December 15 at 5:43 PM
Davita Inc Forecasted to Post FY2018 Earnings of $3.41 Per Share (DVA)Davita Inc Forecasted to Post FY2018 Earnings of $3.41 Per Share (DVA)
www.americanbankingnews.com - December 15 at 5:32 PM
DaVita Kidney Care Issues Statement about DaVita Rx SettlementDaVita Kidney Care Issues Statement about DaVita Rx Settlement
finance.yahoo.com - December 14 at 5:41 PM
DaVita pharmacy unit settles U.S. billing probe for $63.7 millionDaVita pharmacy unit settles U.S. billing probe for $63.7 million
finance.yahoo.com - December 14 at 5:41 PM
DaVita unit to pay $63.7 million to resolve U.S. billing probeDaVita unit to pay $63.7 million to resolve U.S. billing probe
finance.yahoo.com - December 14 at 5:41 PM
Texas-based DaVita Rx to pay nearly $64M in billing disputeTexas-based DaVita Rx to pay nearly $64M in billing dispute
finance.yahoo.com - December 14 at 5:41 PM
DaVita Addresses Physician Fatigue with Investment in DaVita Physician Solutions - PR Newswire (press release)DaVita Addresses Physician Fatigue with Investment in DaVita Physician Solutions - PR Newswire (press release)
www.prnewswire.com - December 14 at 9:50 AM
Insider Selling: Davita Inc (DVA) Insider Sells 7,048 Shares of StockInsider Selling: Davita Inc (DVA) Insider Sells 7,048 Shares of Stock
www.americanbankingnews.com - December 13 at 9:28 PM
DaVita Kidney Care Serves Up Home-Cooked Holidays CookbookDaVita Kidney Care Serves Up 'Home-Cooked Holidays' Cookbook
finance.yahoo.com - December 13 at 5:18 PM
Davita Inc (DVA) Chairman and CEO Kent J Thiry Sold $5.6 million of SharesDavita Inc (DVA) Chairman and CEO Kent J Thiry Sold $5.6 million of Shares
finance.yahoo.com - December 13 at 10:01 AM
Kent J. Thiry Sells 81,800 Shares of Davita Inc (DVA) StockKent J. Thiry Sells 81,800 Shares of Davita Inc (DVA) Stock
www.americanbankingnews.com - December 12 at 11:22 PM
Leanne M. Zumwalt Sells 949 Shares of Davita Inc (DVA) StockLeanne M. Zumwalt Sells 949 Shares of Davita Inc (DVA) Stock
www.americanbankingnews.com - December 12 at 9:08 PM
Davita (DVA) Upgraded to "Outperform" at Robert W. BairdDavita (DVA) Upgraded to "Outperform" at Robert W. Baird
www.americanbankingnews.com - December 12 at 9:04 AM
Davita (DVA) Upgraded to "Buy" by CitigroupDavita (DVA) Upgraded to "Buy" by Citigroup
www.americanbankingnews.com - December 11 at 10:48 PM
Insider Selling: Davita Inc (DVA) Insider Sells 5,608 Shares of StockInsider Selling: Davita Inc (DVA) Insider Sells 5,608 Shares of Stock
www.americanbankingnews.com - December 11 at 8:53 PM
Javier Rodriguez Sells 22,532 Shares of Davita Inc (DVA) StockJavier Rodriguez Sells 22,532 Shares of Davita Inc (DVA) Stock
www.americanbankingnews.com - December 11 at 8:50 PM
Davita Inc Expected to Post FY2019 Earnings of $3.92 Per Share (DVA)Davita Inc Expected to Post FY2019 Earnings of $3.92 Per Share (DVA)
www.americanbankingnews.com - December 11 at 3:00 PM
Citi Upgrades DaVita (DVA) to Buy - StreetInsider.comCiti Upgrades DaVita (DVA) to Buy - StreetInsider.com
www.streetinsider.com - December 11 at 10:26 AM
FY2018 Earnings Estimate for DaVita HealthCare Partners Inc. Issued By KeyCorp (DVA)FY2018 Earnings Estimate for DaVita HealthCare Partners Inc. Issued By KeyCorp (DVA)
www.americanbankingnews.com - December 8 at 12:58 PM
Dow 30 Stock Roundup: UnitedHealth to Buy DaVita Unit for $4.9B, Chevron to Cut CapEx in 2018Dow 30 Stock Roundup: UnitedHealth to Buy DaVita Unit for $4.9B, Chevron to Cut CapEx in 2018
finance.yahoo.com - December 8 at 9:41 AM
UnitedHealth on A.M.Best's Radar After Buyout AnnouncementUnitedHealth on A.M.Best's Radar After Buyout Announcement
finance.yahoo.com - December 8 at 9:41 AM

SEC Filings

Davita (NYSE:DVA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Davita (NYSE:DVA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Davita (NYSE DVA) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.